Status:
COMPLETED
Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study Participants
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborating Sponsors:
Community Programs for Clinical Research on AIDS
Conditions:
HIV Infections
Eligibility:
All Genders
13+ years
Brief Summary
The purpose of this study is to compare the effects of two different anti-HIV drug regimens on HIV transmission risk behavior among SMART study participants.
Detailed Description
It is important to consider the role that HIV infected individuals play in ongoing HIV transmission. Different anti-HIV treatment regimens may lead to variations in HIV transmission risk behavior amon...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Coenrollment in the SMART study
- Parent or guardian willing to provide informed consent, if applicable
Exclusion
Key Trial Info
Start Date :
January 1 2002
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
883 Patients enrolled
Trial Details
Trial ID
NCT00386035
Start Date
January 1 2002
End Date
September 1 2008
Last Update
April 17 2014
Active Locations (58)
Enter a location and click search to find clinical trials sorted by distance.
1
AIDS Healthcare Foundation CRS
Beverly Hills, California, United States, 90211
2
UCSF, Fresno, School of Medicine, Dept. of Internal Medicine CRS
Fresno, California, United States, 93702
3
Dr. M. Estes Med. Practice CRS
Mill Valley, California, United States, 94941-3013
4
Dr. Robert Scott Med. Practice CRS
Oakland, California, United States, 94609